Occudo Quantitative Strategies’s GoodRx Holdings GDRX Stock Holding History

Occudo Quantitative Strategies’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-30,334	Closed	-$237K	–	816
2024 Q2	$237K	Sell	30,334 -3,466	-10%	-$25.7K	0.04%	545
2024 Q1	$240K	Buy	+33,800	New	+$224K	0.04%	541
2023 Q3	–	Sell	-126,831	Closed	-$700K	–	1093
2023 Q2	$700K	Buy	126,831 +49,347	+64%	+$266K	0.07%	431
2023 Q1	$484K	Sell	77,484 -44,669	-37%	-$249K	0.04%	528
2022 Q4	$569K	Sell	122,153 -313,966	-72%	-$1.55M	0.07%	462
2022 Q3	$2.04M	Buy	436,119 +153,254	+54%	+$966K	0.16%	178
2022 Q2	$1.68M	Buy	+282,865	New	+$3.15M	0.14%	228
2021 Q3	–	Sell	-12,380	Closed	-$446K	–	1064
2021 Q2	$446K	Buy	+12,380	New	+$457K	0.07%	461

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Occudo Quantitative Strategies's GDRX Position: Q3 2024 in Review

Occudo Quantitative Strategies sold out of GoodRx Holdings (GDRX) in Q3 2024, closing a stake of 30,334 shares — an estimated $237K sold.

Occudo Quantitative Strategies first reported a position in GDRX in Q2 2021 and held it in 8 quarters. The position peaked at $2.04M in Q3 2022. 168 funds tracked by Wall St. Rank hold GDRX as of Q3 2024.

Occudo Quantitative Strategies reported no remaining GoodRx Holdings position as of Q3 2024 after selling out during the quarter.
Occudo Quantitative Strategies sold 30,334 GoodRx Holdings shares in Q3 2024, an estimated $237K.
Occudo Quantitative Strategies first reported a position in GoodRx Holdings in Q2 2021 and held it in 8 quarters.
Occudo Quantitative Strategies's GoodRx Holdings position peaked at $2.04M in Q3 2022.
168 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.